Table 3.
BAL analyte | Placebo | Aspirin | Difference in median (95% CI) | p Value |
---|---|---|---|---|
TNFα (pg/mL) | 106 (87–154) | 78 (52–128) | 33 (1.91 to 63.74) | 0.03 |
IL-1β (pg/mL) | 43 (26–99) | 37 (19–55) | 13 (−6 to 46) | 0.17 |
IL-1β:IL-1Ra | 0.02 (0.01–0.03) | 0.01 (0.008–0.014) | 0.01 (−.0.001 to 0.02) | 0.07 |
IL-6 (pg/mL) | 857 (606–1263) | 648 (330–835) | 258 (−40 to 526) | 0.07 |
IL-8 (pg/mL) | 448 (321–657) | 346 (275–508) | 102 (−40 to 253) | 0.11 |
MCP-1 (pg/mL) | 547 (412–1055) | 502 (348–888) | 83 (−168 to 363) | 0.45 |
CRP (pg/mL) | 332 (93–1140) | 308 (114–824) | 9 (−351 to 266) | 0.99 |
IL, interleukin; TNFα, tumour necrosis factor α; MCP, Monocyte chemoattractant protein.